FDA
approval
· 2020-08-20
FDA Approved: ZESTORETIC — Supplemental Application (Almatica Pharma Inc.)
Summary
The FDA granted approval of a supplemental application for ZESTORETIC (lisinopril/hydrochlorothiazide) submitted by Almatica Pharma Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ZESTORETIC (LISINOPRIL AND HYDROCHLOROTHIAZIDE)